These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7097222)

  • 1. Sorbitol accumulation in human normal and diabetic platelets.
    O'Malley BC; Bidot-Lopez P; Lee EL; Robertson S
    J Fla Med Assoc; 1982 Jun; 69(6):460-2. PubMed ID: 7097222
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for an increased fatty acid utilization in platelets in diabetes mellitus: its correlation with platelet hyperfunction.
    Musso R; Cacciola RR; Giustolisi R; Cacciola E
    Prog Clin Biol Res; 1988; 283():513-8. PubMed ID: 3211959
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of a sorbitol-rich diet on plasma and erythrocyte sorbitol concentrations in normal and diabetic subjects.
    Malaisse-Lagae F; Couturier E; Dufrane SP; Sener A; Spengler M; Malaisse WJ
    Diabetes Res; 1984 Nov; 1(4):209-11. PubMed ID: 6529892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet function in relation to age and diabetic disease].
    Pernigotti L; Ricauda NA; Molaschi M; Fabris F
    Minerva Med; 1981 Sep; 72(34):2261-4. PubMed ID: 7290452
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced prothrombin and intrinsic factor X activation on blood platelets from diabetic patients.
    Lupu C; Calb M; Ionescu M; Lupu F
    Thromb Haemost; 1993 Oct; 70(4):579-83. PubMed ID: 8115982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of adenine nucleotide metabolism and function of blood platelets in patients with diabetes.
    Michno A; Bielarczyk H; Pawełczyk T; Jankowska-Kulawy A; Klimaszewska J; Szutowicz A
    Diabetes; 2007 Feb; 56(2):462-7. PubMed ID: 17259392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of erythrocyte sorbitol].
    Guillemin G; Boutroux V; Paolaggi F; Batellier L; Segrestaa JM; Rousselet F
    Ann Biol Clin (Paris); 1983; 41(5):325-30. PubMed ID: 6666874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the platelet alpha-adrenoceptor subtypes in diabetes mellitus.
    Das T; Chaudhury U; Lahiri P
    J Assoc Physicians India; 1996 May; 44(5):307-9. PubMed ID: 9282576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
    Asano T; Saito Y; Kawakami M; Yamada N; Sekino H; Hasegawa S;
    J Diabetes Complications; 2004; 18(6):336-42. PubMed ID: 15531183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dilazep on platelet functions and volume change in patients with diabetes mellitus.
    Ozaki Y; Jinnai Y; Yatomi Y; Tawata M; Onaya T; Kume S
    Arzneimittelforschung; 1993 May; 43(5):536-9. PubMed ID: 8392344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mobilization of intracellular Ca2+ by ADP and thrombin in platelets of patients with diabetes mellitus with vascular complications].
    Kubatiev AA; Balashova TS; Rud'ko IA; Tomilova EN
    Biull Eksp Biol Med; 1996 Jan; 121(1):112-5. PubMed ID: 8679990
    [No Abstract]   [Full Text] [Related]  

  • 13. [New diagnostic tests for diabetes mellitus. Sorbitol].
    Hotta N; Sakamoto N
    Nihon Rinsho; 1989 Nov; 47(11):2477-82. PubMed ID: 2601060
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets.
    Watala C; Gwoździński K; Pluskota E; Pietrucha T; Walkowiak B; Trojanowski Z; Cierniewski CS
    Thromb Haemost; 1996 Jan; 75(1):147-53. PubMed ID: 8713794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorbitol concentration in the plasma and erythrocytes of diabetic subjects.
    Somers G; Depoorter I; Sener A; Malaisse WJ
    Diabetes Care; 1982; 5(3):319-21. PubMed ID: 7173001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monosaccharides and polyols in diabetes mellitus and uremia.
    Aloia JF
    J Lab Clin Med; 1973 Nov; 82(5):809-17. PubMed ID: 4746819
    [No Abstract]   [Full Text] [Related]  

  • 17. Advanced glycation end products and sorbitol in blood from differently compensated diabetic dogs.
    Comazzi S; Bertazzolo W; Bonfanti U; Spagnolo V; Sartorelli P
    Res Vet Sci; 2008 Jun; 84(3):341-6. PubMed ID: 17631369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on platelets in diabetic patients. Part 2: Compositional changes of lipid in hyper-aggregation platelets (author's transl)].
    Hiramatsu K; Nozaki H; Arimori S
    Rinsho Ketsueki; 1981 Jun; 22(6):849-54. PubMed ID: 7334612
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin-dependent diabetes.
    van Griensven JM; Jusko WJ; Lemkes HH; Kroon R; Verhorst CJ; Chiang ST; Cohen AF
    Clin Pharmacol Ther; 1995 Dec; 58(6):631-40. PubMed ID: 8529328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane biosynthesis in platelets of diabetic and coronary artery diseased patients.
    Butkus A; Shirey EK; Schumacher OP
    Artery; 1982; 11(3):238-51. PubMed ID: 7184495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.